Commentary on Ferumoxytol and Beyond: Navigating the Shift Away From GBCAs in Neuro‐Oncology
Journal of Magnetic Resonance Imaging · 2026-12 · 64 (6) · 1751-1752
DOI: 10.1002/jmri.70468 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, online erschienen am 22.07.2026. Verfasst von Vera C Keil und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
- Amsterdam Neuroscience, Brain Imaging, Amsterdam, the Netherlands.
- Department of Radiology, Faculty of Medicine, Adnan Menderes University, Aydın, Turkey.
ORCID-Profile: Vera C Keil, Yelda Özsunar
Zitieren
APA
Keil, V. C., & Özsunar, Y. (2026). Commentary on Ferumoxytol and Beyond: Navigating the Shift Away From GBCAs in Neuro‐Oncology. Journal of Magnetic Resonance Imaging, 64(6), 1751-1752. https://doi.org/10.1002/jmri.70468
Vancouver
Keil VC, Özsunar Y. Commentary on Ferumoxytol and Beyond: Navigating the Shift Away From GBCAs in Neuro‐Oncology. Journal of Magnetic Resonance Imaging. 2026;64(6):1751-1752. doi:10.1002/jmri.70468
BibTeX
@article{Keil2026,
author = {Keil, Vera C and Özsunar, Yelda},
title = {Commentary on Ferumoxytol and Beyond: Navigating the Shift Away From GBCAs in Neuro‐Oncology},
journal = {Journal of Magnetic Resonance Imaging},
year = {2026},
volume = {64},
number = {6},
pages = {1751--1752},
doi = {10.1002/jmri.70468}
}
EUVIMED